Results 241 to 250 of about 30,558 (294)

Developments in image-based colorimetric analysis methods and applications of CIElab color space in pharmaceutical sciences: A narrative review. [PDF]

Int J Pharm X
Marefat S, Shayanfar A, Monajjemzadeh F.
europepmc   +1 more source

Science Behind a Paywall: Restricted Access Limits the Promise of Artificial Intelligence

Learned Publishing, Volume 39, Issue 3, July 2026.
Haoyi Zheng, Huichun Zhan
wiley   +1 more source

Artificial Intelligence and Corruption: Opportunities and Challenges in the Health Sector. [PDF]

Int J Health Plann Manage
Del Rey-Puech P, Balabanova D, McKee M.
europepmc   +1 more source

National consultation workshop on private sector participation in animal health services in Kenya: Workshop report

, 2020
Kiara, Henry K., Makau, Joyce, Nganga, Esther, Njiru, Muthoni, Wamwere-Njoroge, George J.   +4 more
core  

Some of the next articles are maybe not open access.

Related searches:

Counterfeit and substandard antimalarial drugs in Cambodia

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006
Counterfeit and substandard antimalarial drugs can cause death and contribute to the growing malaria drug resistance problem, particularly in Southeast Asia. Since 2003 in Cambodia the quality of antimalarial drugs both in the public and private health sector is regularly monitored in sentinel sites. We surveyed 34% of all 498 known facilities and drug
C T, Lon, R, Tsuyuoka, S, Phanouvong, N, Nivanna, D, Socheat, C, Sokhan, N, Blum, E M, Christophel, A, Smine   +8 more
exaly   +3 more sources

Counterfeit drugs: analytical techniques for their identification

Analytical and Bioanalytical Chemistry, 2010
In recent years, the number of counterfeit drugs has increased dramatically, including not only "lifestyle" products but also vital medicines. Besides the threat to public health, the financial and reputational damage to pharmaceutical companies is substantial.
Myriam Malet-Martino, Véronique Gilard   +1 more
exaly   +3 more sources

Drug counterfeiting and decentralized whistleblowers

Drug Discovery Today, 2022
To tackle the devastating issue of drug counterfeiting, the US Food and Drug Administration (FDA) has initiated a pilot project in which 24 companies in the pharmaceutical supply chain use blockchain technology to track and trace drug deliveries among manufacturers, distributors, hospitals, clinics, and pharmacies.
Hossein, Omidian, Yadollah, Omidi
openaire   +2 more sources

Drug Counterfeiting

International Journal of Pharmaceutical Medicine, 2005
Recent literature suggests that drug counterfeiting is not just a national but also an international concern, affecting health policy makers, drug manufacturers, wholesalers, drug enforcement agents, healthcare providers and patients across the globe. It is also clear that counterfeiting is not limited to the least developed nations but is increasingly
Albert I. Wertheimer, Thomas M. Santella
openaire   +1 more source

Counterfeit drugs: an Australian perspective

Medical Journal of Australia, 2016
Past use-by date or poor packaging Reduced efficacy Ahighlighted the global impact of falsified or substandard drugs. In countries with stringent legislation, governance and customs, such as Australia, the prevalence of counterfeit medications is low and estimated by the World Health Organization to be less than 1% of market value.
Conor C, Hensey, Amanda, Gwee
openaire   +2 more sources

Counterfeit drugs: a growing global threat

Lancet, The, 2012
exaly   +3 more sources